Research and development in the emerging fields of biotechnology, including human enhancement and direct-effect genetic weapons, may very well change the nature of war and international politics. This biotech revolution in military affairs will offer great advantages to the United States and other technologically advanced states, but raises many new questions about just war and bioethics. Biotechnology and International Security contextualizes the militarization of biotechnology by examining its strategic uses, the nature of bioweapons, and the overall impact on warfare and security. The book looks at the many emerging military applications of biotechnology and provides a nontechnical assessment of how a wide range of technologies are influencing war fighting, international balance of power, and homeland security. It offers a thorough introduction to bioweapons and biosecurity challenges, along with the resulting ethical and policy dilemmas.

This book accessibly and expertly details the history and implications of the BWC—the Biological and Toxin Weapons Convention—a controversial arms control agreement drafted in the 1970’s meant to supplement the Geneva protocol for warfare from decades earlier. That treaty banned the use of biological weapons in modern warfare, but failed to ban their development, transport or trafficking, holes the BWC aimed to fill, but are still contested to this day. Daniel M. Gerstein, a former Army Colonel and current Under Secretary in the Department of Homeland Security, traces the origins of the treaty and its many complications, past and present, while prescribing a way for the world’s military leaders to move forward with regards to (what Gerstein sees will be and already is) “the most important arms control treaty of the 21st Century.” The strength and enforcement of the treaty are at a crossroads, and it is important for both professionals and students of the military and international affairs to know exactly what a failure to honor, improve and uphold the BWC would mean for international security.

"Biological weapons are widely feared, yet rarely used. Biological weapons were the first weapon prohibited by an international treaty, yet the proliferation of these weapons increased after they were banned in 1972. Biological weapons are frequently called 'the poor man's atomic bomb,' yet they cannot provide the same deterrent capability as nuclear weapons. One of my goals in this book is to explain the underlying principles of these apparent paradoxes."—from Living Weapons Biological weapons are the least well understood of the so-called weapons of mass destruction. Unlike nuclear and chemical weapons, biological weapons are composed of, or derived from, living organisms. In Living Weapons, Gregory D. Koblentz provides a comprehensive analysis of the unique challenges that biological weapons pose for international security. At a time when the United States enjoys overwhelming conventional military superiority, biological weapons have emerged as an attractive means for less powerful states and terrorist groups to wage asymmetric warfare. Koblentz also warns that advances in the life sciences have the potential to heighten the lethality and variety of biological weapons. The considerable overlap between the equipment, materials and knowledge required to develop biological weapons, conduct civilian biomedical research, and develop biological defenses creates a multiuse dilemma that limits the effectiveness of verification, hinders civilian oversight, and complicates threat assessments. Living Weapons draws on the American, Soviet, Russian, South African, and Iraqi biological weapons programs to enhance our understanding of the special challenges posed by these weapons for arms control, deterrence, civilian-military relations, and intelligence. Koblentz also examines the aspirations of terrorist groups to develop these weapons and the obstacles they have faced. Biological weapons, Koblentz argues, will continue to threaten international security until defenses against such weapons are improved, governments can reliably detect biological weapon activities, the proliferation of materials and expertise is limited, and international norms against the possession and use of biological weapons are strengthened.

Using the concept of innovation capacity, this book, using recent field data from countries in Asia and Africa, competently demonstrates how biotechnology can contribute to sustainable economic development. The approach articulates the imperative for developing countries to build up specific capabilities backed up by policies and institutions.

Based on a series of regional meetings on university campuses with officials from the national security community and academic research institutions, this report identifies specific actions that should be taken to maintain a thriving scientific research environment in an era of heightened security concerns. Actions include maintaining the open exchange of scientific information, fostering a productive environment for international scholars in the U.S., reexamining federal definitions of sensitive but unclassified research, and reviewing policies on deemed export controls. The federal government should establish a standing entity, preferably a Science and Security Commission, that would review policies regarding the exchange of information and the participation of foreign-born scientists and students in research.

This book examines how emergent trends in innovation and its governance are raising new and old questions about how to control technology. It develops a new framework for understanding how emergent fields of science and technology emerge as security concerns; and the key challenges these fields pose from a global security perspective. The study focuses on the politics which have surrounded the emergent field of Synthetic Biology, a field which has become emblematic of both the potentials and limits of more preemptive approaches to governance. This highly accessible work will be of interest to both scholars and practitioners working on the ethical responsibilities of innovators and the assessment of emergent technology as well as the global governance of weapons.

In recent years much has happened to justify an examination of biological research in light of national security concerns. The destructive application of biotechnology research includes activities such as spreading common pathogens or transforming them into even more lethal forms. Policymakers and the scientific community at large must put forth a vigorous and immediate response to this challenge. This new book by the National Research Council recommends that the government expand existing regulations and rely on self-governance by scientists rather than adopt intrusive new policies. One key recommendation of the report is that the government should not attempt to regulate scientific publishing but should trust scientists and journals to screen their papers for security risks, a task some journals have already taken up. With biological information and tools widely distributed, regulating only U.S. researchers would have little effect. A new International Forum on Biosecurity should encourage the adoption of similar measures around the world. Seven types of risky studies would require approval by the Institutional Biosafety Committees that already oversee recombinant DNA research at some 400 U.S. institutions. These "experiments of concern" include making an infectious agent more lethal and rendering vaccines powerless.